TickerTry: NVDA · AAPL · PLTR · NFLX
NASDAQ · Healthcare · Drug Manufacturers - General

Amgen Inc.

AMGN

Amgen Inc. CEO Robert A. Bradway · Market cap $192.6B.

$356.84
+4.02 · +1.14%
52w hi $391.2952w lo $269.77
59
ROUTINE
Current InsiderScore
Corp · 90d
0
0 buys · 0 sales
Cong · 90d
5
1 buys · 4 sales
Signals ≥ 60 · 12mo
0
0 strong · 0 notable
Analyst consensus
Section 01

Recent Form 4 filings

3 filings on file
DateInsiderRoleActionSharesPriceValueScore
Feb 26Esteban SantosEVP, OperationsSell30,501$379.12−$11.56M37
Feb 26Esteban SantosEVP, OperationsSell24,291$379.12−$9.21M33
Nov 12Murdo GordonEVP, Global Commercial OpsSell6,879$336.83−$2.32M30
Section 02

Recent STOCK Act disclosures

9 disclosures on file
DisclosedLegislatorChamber · StateActionRangeMidpointDelayScore
Jun 15David TaylorHouse · OHBuy$1,001 - $15,000$8K10 d43
May 11Maria Elvira SalazarHouse · FLSell$15,001 - $50,000$33K24 d59
May 01Mark WarnerSenate · VASell$1,001 - $15,000$8K24 d56
May 01Mark WarnerSenate · VASell$1,001 - $15,000$8K24 d59
May 01Mark WarnerSenate · VASell$1,001 - $15,000$8K25 d41
Apr 22Maria Elvira SalazarHouse · FLBuy$15,001 - $50,000$33K29 d59
Mar 09David TaylorHouse · OHSell$1,001 - $15,000$8K11 d43
Feb 03David TaylorHouse · OHSell$1,001 - $15,000$8K5 d46
Feb 03David TaylorHouse · OHBuy$1,001 - $15,000$8K18 d39
Section 03

InsiderScore history

Rolling 12 months · peak score per month
75 · STRONG60 · NOTABLE40 · ROUTINE
JulAugSepOctNovDecJanFebMarAprMayJun
/to search